Skip to main content
letter
. 2020 Jun 25;27(9):e50–e51. doi: 10.1111/ene.14320

Table 1.

Neurorehabilitation in the COVID‐19 world: current challenges and actions to minimize COVID‐19 risks in different settings of neurorehabilitation, and possible drawbacks to be overcome before continuing on previous healthcare activities.

Challenge Actions Drawbacks
Reduce inpatient and outpatient visits Telerehabilitation and teleconsultations

To be made widely available

Not feasible for complex diseases or severe symptoms

Periodic in‐person assessments needed

Outpatient and day service Screening for body temperature and active respiratory symptoms Asymptomatic patients are missed
SARS‐CoV‐2 oro‐pharyngeal swab and/or serological testing, according to local regulations To be made widely available
Physical distancing

Reduced number of simultaneous treatments

Longer opening hours

Caregivers and visitors not allowed to access

Appropriate personal protective equipment for operators and patients To be made available at population level
Inpatient Screening for body temperature and active respiratory symptoms Asymptomatic patients are missed
SARS‐CoV‐2 oro‐pharyngeal swab and/or serological testing on admission, according to local regulations To be made widely available
Separate pathways To be considered within hospital reorganization plans
Staff and patients’ protection Personal protective equipment To be made widely available
Robot‐assisted neurorehabilitation To be made widely available
Contact tracing apps Depending on national regulations
Patients with active COVID‐19 infection NeuroCOVID‐19 wards and/or COVID‐19 hospitals To be made widely available